KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Feb 02, 2026 - 3:59PM >>  ABB India 5460.7  [ 0.44% ]  ACC 1639.95  [ 1.10% ]  Ambuja Cements 510.65  [ 2.68% ]  Asian Paints 2401.15  [ 1.79% ]  Axis Bank 1311.6  [ -2.00% ]  Bajaj Auto 9490.85  [ 0.05% ]  Bank of Baroda 277.65  [ -0.70% ]  Bharti Airtel 1965.35  [ 0.98% ]  Bharat Heavy 258.1  [ 2.44% ]  Bharat Petroleum 366.65  [ 2.16% ]  Britannia Industries 5868  [ 1.91% ]  Cipla 1313  [ -0.97% ]  Coal India 423.15  [ 0.95% ]  Colgate Palm 2131  [ 1.17% ]  Dabur India 500.2  [ -0.41% ]  DLF 628.3  [ 2.36% ]  Dr. Reddy's Labs 1182.35  [ -0.03% ]  GAIL (India) 160.35  [ -1.20% ]  Grasim Industries 2779.1  [ 1.65% ]  HCL Technologies 1676.1  [ 0.46% ]  HDFC Bank 927.3  [ 0.77% ]  Hero MotoCorp 5622.55  [ 2.08% ]  Hindustan Unilever 2355.8  [ 0.20% ]  Hindalco Industries 932.15  [ 2.68% ]  ICICI Bank 1351  [ 1.31% ]  Indian Hotels Co. 666.25  [ 0.66% ]  IndusInd Bank 907.15  [ 1.30% ]  Infosys 1629  [ -1.85% ]  ITC 314.8  [ 1.68% ]  Jindal Steel 1124.45  [ 1.71% ]  Kotak Mahindra Bank 408.2  [ 0.15% ]  L&T 3922  [ 2.86% ]  Lupin 2124.1  [ -0.68% ]  Mahi. & Mahi 3463.25  [ 2.97% ]  Maruti Suzuki India 14387.05  [ 1.31% ]  MTNL 31.16  [ -3.26% ]  Nestle India 1307.6  [ 2.43% ]  NIIT 77.19  [ -1.23% ]  NMDC 81.6  [ 1.52% ]  NTPC 350.4  [ 1.39% ]  ONGC 254  [ -0.12% ]  Punj. NationlBak 122.05  [ 0.41% ]  Power Grid Corpo 270.15  [ 7.61% ]  Reliance Industries 1390.15  [ 3.28% ]  SBI 1028.45  [ 1.11% ]  Vedanta 661  [ 0.94% ]  Shipping Corpn. 216.35  [ 1.15% ]  Sun Pharmaceutical 1628.9  [ 1.16% ]  Tata Chemicals 726.15  [ -2.27% ]  Tata Consumer Produc 1125.3  [ 3.36% ]  Tata Motors Passenge 362.9  [ 5.34% ]  Tata Steel 188.6  [ 1.62% ]  Tata Power Co. 358.75  [ 1.30% ]  Tata Consultancy 3168.45  [ -0.52% ]  Tech Mahindra 1724.5  [ 0.52% ]  UltraTech Cement 12537.6  [ 2.05% ]  United Spirits 1345.9  [ 0.70% ]  Wipro 242.2  [ 0.06% ]  Zee Entertainment En 82.18  [ 0.78% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

ARVEE LABORATORIES (INDIA) LTD.

02 February 2026 | 03:40

Industry >> Chemicals - Speciality

Select Another Company

ISIN No INE006Z01016 BSE Code / NSE Code / Book Value (Rs.) 28.53 Face Value 10.00
Bookclosure 24/09/2025 52Week High 291 EPS 1.95 P/E 79.87
Market Cap. 171.46 Cr. 52Week Low 127 P/BV / Div Yield (%) 5.45 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
The Company was incorporated as Arvee Laboratories (India) Private Limited under the provisions of the Companies Act, 1956 vide certificate of incorporation dated January 27, 2012 in Ahmedabad, Gujarat. Subsequently, the name of the company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public company vide shareholder's approval dated September 11, 2017 and vide fresh certificate of incorporation dated September 19, 2017. KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY 2012 - The Company was incorporated as Arvee Laboratories (India) Private Limited. 2013 - Acquired land, building and machineries from Skylink Chemicals Private Limited and started manufacturing unit. - Started construction of its first plant for Thiophene Derivatives. - Completes construction and commissioning of its Thiophene Derivatives Plant. 2014 - Plant inspected and approved by leading India pharmaceutical manufacturer for supply of Thiophene Derivatives. - Started construction of plant for Sulfo and Nitro Derivatives of Isophthalic Acid. - Received ISO 9001:2008 accreditation for NABCB and DAKKS from TUV NORD. - Plant inspected and approved by an American X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer. - Plant inspected and approved by a European X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer. 2015 - Completed construction and commissioning of plant for Nitro Derivatives of Isophthalic Acid. - After receiving inspection approval, our Company gets order for yearly supply of Nitro Derivatives of Isophthalic Acid to leading contrast media manufacturer in the United States of America. - Export to United States of America (USA) started. - Plant inspected and approved by European manufacturer for supply of Thiophene Derivatives. - Export of Thiophene Derivatives started to Europe. 2016 - Receives internal approvals for our Nitro Derivatives of Isophthalic acid from leading XRay contrast media manufacturer in Europe. - Receive approval for our Sulfo Derivatives of Isophthalic acid from a large polymer manufacturer in the United States of America and received yearly order for supply of Sulfo Derivatives to the USA. - Crossed turnover of Rs. 25 crores. 2017 - Plant inspected and approved by an American X-ray contrast media manufacturer who has the largest market share in the world and started of pilot trials with the manufacturer. - Received order for commercial trials of Nitro Derivatives of Isophthalic acid from the largest manufacturer of X-ray contrast media manufacturer in the world. - The name of our Company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public limited company. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1.